HA
HHLR Advisors Portfolio holdings
AUM
$3.1B
This Quarter Return
+5.39%
1 Year Return
+44.54%
3 Year Return
+121.93%
5 Year Return
+166.86%
10 Year Return
–
AUM
$9.71B
AUM Growth
+$9.71B
(-4%)
Cap. Flow
-$725M
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
61.24%
Holding
100
New
9
Increased
6
Reduced
17
Closed
11
Top Buys
| 1 |
Airbnb
ABNB
|
$324M |
| 2 |
Vipshop
VIPS
|
$171M |
| 3 |
Alibaba
BABA
|
$131M |
| 4 |
MINISO
MNSO
|
$111M |
| 5 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
$42.6M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$422M |
| 2 |
Zoom
ZM
|
$367M |
| 3 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
$351M |
| 4 |
GDS Holdings
GDS
|
$216M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$103M |
Sector Composition
| 1 | Healthcare | 42.52% |
| 2 | Consumer Discretionary | 24.31% |
| 3 | Technology | 11.89% |
| 4 | Communication Services | 10.14% |
| 5 | Financials | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gossamer Bio
GOSS
$587M
| $60.3M | 0.62% |
7,420,974
| – | – |
|
|
TUYA
27
Tuya Inc
TUYA
$1.53B
| $58.2M | 0.6% |
2,375,000
| – | – |
|
|
BPMC
28
DELISTED
Blueprint Medicines
BPMC
| $55.9M | 0.58% |
635,302
-123,389
| -16% | -$10.9M |
|
29
Affiliated Managers Group
AMG
$6.48B
| $51.7M | 0.53% |
335,073
| – | – |
|
30
Otis Worldwide
OTIS
$33.5B
| $50.3M | 0.52% |
614,556
| – | – |
|
31
Instil Bio
TIL
$197M
| $46.1M | 0.47% |
2,385,457
| – | – |
|
32
NIO
NIO
$14B
| $45.7M | 0.47% |
859,200
+732,000
| +575% | +$38.9M |
|
33
Aligos Therapeutics
ALGS
$73M
| $44.1M | 0.45% |
2,165,064
| – | – |
|
34
TSMC
TSM
$1.19T
| $43.3M | 0.45% |
360,495
| – | – |
|
|
DIDI
35
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
| $42.6M | 0.44% |
+3,016,060
| New | +$42.6M |
|
36
Kanzhun
BZ
$11B
| $41.6M | 0.43% |
+1,050,000
| New | +$41.6M |
|
37
Akero Therapeutics
AKRO
$3.63B
| $41.1M | 0.42% |
1,656,673
| – | – |
|
38
Kiniksa Pharmaceuticals
KNSA
$2.62B
| $40.7M | 0.42% |
2,920,023
| – | – |
|
39
XPeng
XPEV
$19.2B
| $39.8M | 0.41% |
896,500
+237,905
| +36% | +$10.6M |
|
40
Lyell Immunopharma
LYEL
$219M
| $38.1M | 0.39% |
+2,348,965
| New | +$38.1M |
|
|
41
GDS Holdings
GDS
$6.44B
| $30.6M | 0.32% |
390,000
-2,753,623
| -88% | -$216M |
|
42
Huazhu Hotels Group
HTHT
$11.2B
| $30.6M | 0.31% |
578,902
| – | – |
|
43
Melco Resorts & Entertainment
MLCO
$3.94B
| $28.2M | 0.29% |
1,698,877
| – | – |
|
44
Root
ROOT
$1.37B
| $28.1M | 0.29% |
2,600,000
| – | – |
|
45
Apple
AAPL
$3.52T
| $27.4M | 0.28% |
200,000
| – | – |
|
|
FMTX
46
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $27.4M | 0.28% |
1,100,000
| – | – |
|
47
Legend Biotech
LEGN
$6.59B
| $26.7M | 0.27% |
650,000
| – | – |
|
|
EM
48
Smart Share Global Ltd
EM
$335M
| $24.8M | 0.25% |
+4,080,000
| New | +$24.8M |
|
49
Axsome Therapeutics
AXSM
$6.06B
| $24.3M | 0.25% |
360,000
| – | – |
|
50
ACM Research
ACMR
$1.71B
| $22.9M | 0.24% |
223,585
| – | – |
|